Rossitto Erica 4
4 · HCA Healthcare, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
HCA SVP Erica Rossitto Receives Award; 418 Shares Withheld
What Happened
Erica Rossitto, Senior Vice President & Chief Nurse Executive at HCA Healthcare (HCA), received 1,676 shares on 2026-02-10 as the settlement of vested performance share units (PSUs). To satisfy tax withholding on the award, 418 of those shares were surrendered/disposed at $502.05 per share, generating about $209,857. Net shares delivered to Rossitto from this vesting: 1,258.
Key Details
- Transaction dates: 2026-02-10 (award vesting and tax withholding sale); Form 4 filed 2026-02-12 (timely).
- Award: 1,676 shares (code A) issued at $0.00 — these are vested PSUs converted to shares.
- Tax withholding: 418 shares (code F) disposed at $502.05 each, total ≈ $209,857 to cover tax obligations.
- Net shares received from vesting: 1,258 (1,676 granted − 418 withheld).
- Footnote: The PSUs were originally granted 1/30/2023 as 838 units that vested at 200% based on cumulative 2023–2025 EPS performance.
- Shares owned after transaction: not reported in the supplied data (this report reflects the award and withholding only).
- Filing timeliness: filed within the normal 2-business-day window (not marked late).
Context
This was a performance-based award settlement (PSUs) rather than an open-market purchase or discretionary sale. Withholding or surrender of shares to cover taxes is a routine administrative step and does not necessarily signal the insider’s market view. The vesting at 200% reflects achievement of the company’s multi-year EPS performance target (per the footnote).
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-10+1,676→ 10,825 total - Tax Payment
Common Stock
2026-02-10$502.05/sh−418$209,857→ 10,407 total
Footnotes (1)
- [F1]On January 30, 2023, the reporting person was granted 838 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.